(19)
(11) EP 4 815 935 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898576.4

(22) Date of filing: 25.11.2024
(51) International Patent Classification (IPC): 
A61K 31/395(2006.01)
A61K 31/18(2006.01)
A61K 31/47(2006.01)
A61K 31/33(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 45/06; A61K 31/519; A61K 31/4409
 
C-Sets:
  1. A61K 31/519, A61K 2300/00;
  2. A61K 31/4409, A61K 2300/00;

(86) International application number:
PCT/US2024/057259
(87) International publication number:
WO 2025/117429 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 30.11.2023 US 202363604227 P

(71) Applicant: The Children's Medical Center Corporation
Boston, MA 02115 (US)

(72) Inventors:
  • ITALIANO, Joseph E.
    Chestnut Hill, Massachusetts 02457 (US)
  • BECKER, Isabelle C.
    Jamaica Plain, Massachusetts 02130 (US)

(74) Representative: Purdylucey Intellectual Property 
23 Ely Place
Dublin 2 D02 N285
Dublin 2 D02 N285 (IE)

   


(54) METHODS AND COMPOSITIONS FOR THE TREATMENT OF BLOOD CANCER